KEEFE SINGISER PARTNERS, FKA KEEFE STRATEGIES LLC

Lobbying for CVS HEALTH · â€‹Pharmacy innovation and healthcare

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate · $25,000.00 income · posted Apr 10, 2025

Lobbying activity 2

Health Issues

Issues involving lowering the cost of healthcare and prescription drug prices; quality healthcare, patient outcomes, and healthcare delivery.

Pharmacy

Issues encompassing general education regarding the pharmacy benefit manager/pharmacy industry. Issues related to access and affordability of healthcare, prescription drugs, and generic drugs.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.